Statements (74)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:aimsTo |
improve patient outcomes
specific patient populations |
| gptkbp:allows |
reduction of immunogenicity
|
| gptkbp:associated_with |
industry trends
therapeutic antibodies therapeutic advancements Xencor's_drug_candidates |
| gptkbp:basedOn |
XmAb technology
|
| gptkbp:compatibleWith |
various therapeutic targets
|
| gptkbp:contributedTo |
therapeutic innovations
|
| gptkbp:developedBy |
gptkb:Xencor
|
| gptkbp:enables |
modification of antibodies
|
| gptkbp:facilitates |
targeted therapy
|
| gptkbp:has_a_focus_on |
clinical research
scientific inquiry investor interest |
| gptkbp:hasRelatedPatent |
oncology
autoimmune diseases |
| https://www.w3.org/2000/01/rdf-schema#label |
XmAb® platform
|
| gptkbp:impact |
computational modeling
|
| gptkbp:is_a |
commercial product
|
| gptkbp:is_a_subject_of |
market analysis
patents scientific publications regulatory review therapeutic success |
| gptkbp:is_a_tool_for |
drug_discovery
|
| gptkbp:is_characterized_by |
flexible design
|
| gptkbp:is_designed_to |
reduce side effects
address unmet medical needs customized therapies enhance efficacy enhance patient compliance improve drug delivery maximize therapeutic potential |
| gptkbp:is_governed_by |
regulatory standards
|
| gptkbp:is_integrated_with |
other technologies
|
| gptkbp:is_involved_in |
collaborative research
drug development process clinical trials for new therapies |
| gptkbp:is_part_of |
biotech ecosystem
Xencor's_research_initiatives Xencor's_business_model Xencor's_future_plans Xencor's_innovation_strategy Xencor's_portfolio |
| gptkbp:is_recognized_for |
healthcare_professionals
its innovative approach biopharmaceutical industry its impact on patient care its contribution to medicine biotech investors its role in advancing healthcare. |
| gptkbp:is_supported_by |
scientific research
preclinical studies clinical evidence |
| gptkbp:is_used_in |
clinical trials
personalized medicine research institutions pharmaceutical development clinical applications targeted drug delivery biologics manufacturing |
| gptkbp:isAssociatedWith |
Xencor's_strategy
Xencor's_technology_stack |
| gptkbp:knownFor |
its versatility
|
| gptkbp:leadership |
antibody therapeutics
|
| gptkbp:performance |
large-scale production
|
| gptkbp:products |
Xencor's_innovation_efforts
|
| gptkbp:provides |
enhanced pharmacokinetics
|
| gptkbp:supports |
bispecific antibodies
|
| gptkbp:usedFor |
antibody engineering
|
| gptkbp:was_a_result_of |
extensive research
|